p66Shc Deletion Confers Vascular Protection in Advanced Atherosclerosis in Hypercholesterolemic Apolipoprotein E Knockout Mice

被引:46
作者
Martin-Padura, Ines [3 ,4 ]
de Nigris, Filomena [5 ,7 ]
Migliaccio, Enrica [3 ,4 ]
Mansueto, Gelsomina [6 ]
Minardi, Simone [3 ,4 ]
Rienzo, Monica [5 ,7 ]
Lerman, Lilach O. [8 ]
Stendardo, Massimo [3 ,4 ]
Giorgio, Marco [3 ,4 ]
De Rosa, Gaetano [6 ]
Pelicci, Pier Giuseppe [3 ,4 ]
Napoli, Claudio [1 ,2 ,5 ]
机构
[1] Univ Naples Federico II, Dept Gen Pathol, Div Clin Pathol, Sch Med, Naples, Italy
[2] Univ Naples Federico II, Sch Med, Excellence Res Ctr Cardiovasc Dis, Naples, Italy
[3] EIO, Milan, Italy
[4] IFOM, Milan, Italy
[5] Univ Naples 2, Dept Gen Pathol, Div Clin Pathol, Sch Med, I-80138 Naples, Italy
[6] Univ Naples Federico II, Dept Human Pathol, Naples, Italy
[7] Univ Naples 2, Excellence Res Ctr Cardiovasc Dis, Sch Med, I-80138 Naples, Italy
[8] Mayo Clin, Coll Med, Div Nephrol & Hypertens, Rochester, MN USA
来源
ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH | 2008年 / 15卷 / 5-6期
关键词
Atherosclerosis; ApoE; p66Shc;
D O I
10.1080/10623320802487791
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Previous studies showed that p66Shc -/- mice on a very-high-fat diet (HFD) had reduced oxidative stress, foam cell, and early atherosclerotic lesion formation. Here, the authors have used hypercholesterolemic apolipoprotein E (ApoE-/-) mice to investigate the role of p66Shc deletion in advanced atheroma. The authors generated mice deficient of both ApoE and p66Shc genes (ApoE-/- /p66Shc -/-). They used microsatellite polymerase chain reaction (PCR) analysis to analyze the genetic background and considered only animals with a constant percentages of C57B6L and 129SV background strands (it was obtained the 50.3% 6.4% of C57B6L background). Computer-assisted analysis revealed that advanced atherosclerotic lesions in ApoE-/-/p66Shc +/+ were significantly larger than those observed in ApoE-/-/p66Shc -/-. Accordingly, the lipid-laden macrophage foam cells and oxidation-specific epitopes in ApoE-/-/p66shc +/+ HFD-treated groups were higher than those observed in normal diet (ND)-treated groups. Thus, p66Shc -/- plays an important protective role also against advanced atherosclerotic lesion formation. Finally, the authors have used microarray to investigate major changes in gene expression in aortas of mice with ApoE-/-/p66Shc -/- background treated with a very HFD in comparison to ApoE-/-/p66Shc +/+ (these data have been confirmed by by real-time PCR and immunohistochemistry). DAVID (Database for Annotation, Visualization and Integrated Discovery) analysis revealed that CD36 antigen (CD36), tissue inhibitor of metalloproteinase 2 (TIMP2), apolipoprotein E (ApoE), acetyl-coenzyme A acetyltransferase 1 (ACAT1), and thrombospondin 1 (THBS1) can be involved in p66 deletion-dependent vascular protection through the adipocytokine/lipid signaling pathway.
引用
收藏
页码:276 / 287
页数:12
相关论文
共 39 条
[1]   MAPPING GENES IN THE MOUSE USING SINGLE-STRAND CONFORMATION POLYMORPHISM ANALYSIS OF RECOMBINANT INBRED STRAINS AND INTERSPECIFIC CROSSES [J].
BEIER, DR ;
DUSHKIN, H ;
SUSSMAN, DJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (19) :9102-9106
[2]   Matrix metalloproteinases 2 and 9 in human atherosclerotic and non-atherosclerotic cerebral aneurysms [J].
Caird, J. ;
Napoli, C. ;
Taggart, C. ;
Farrell, M. ;
Bouchier-Hayes, D. .
EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 (10) :1098-1105
[3]   Genetic deletion of p66Shc adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress [J].
Camici, Giovanni G. ;
Schiavoni, Marzia ;
Francia, Pietro ;
Bachschmid, Markus ;
Martin-Padura, Ines ;
Hersberger, Martin ;
Tanner, Felix C. ;
Pelicci, PierGiuseppe ;
Volpe, Massimo ;
Anversa, Piero ;
Luescher, Thomas F. ;
Cosentino, Francesco .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (12) :5217-5222
[4]  
Daviet L, 1997, THROMB HAEMOSTASIS, V78, P65
[5]   Apolipoprotein E and atherosclerosis: insight from animal and human studies [J].
Davignon, J ;
Cohn, JS ;
Mabile, L ;
Bernier, L .
CLINICA CHIMICA ACTA, 1999, 286 (1-2) :115-143
[6]   CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells [J].
Dawson, DW ;
Pearce, SFA ;
Zhong, RQ ;
Silverstein, RL ;
Frazier, WA ;
Bouck, NP .
JOURNAL OF CELL BIOLOGY, 1997, 138 (03) :707-717
[7]   DAVID: Database for annotation, visualization, and integrated discovery [J].
Dennis, G ;
Sherman, BT ;
Hosack, DA ;
Yang, J ;
Gao, W ;
Lane, HC ;
Lempicki, RA .
GENOME BIOLOGY, 2003, 4 (09)
[8]   CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism [J].
Febbraio, M ;
Hajjar, DP ;
Silverstein, RL .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (06) :785-791
[9]   Deletion of p66shc gene protects against age-related endothelial dysfunction [J].
Francia, P ;
Gatti, CD ;
Bachschmid, M ;
Martin-Padura, I ;
Savoia, C ;
Migliaccio, E ;
Pelicci, PG ;
Schiavoni, M ;
Lüscher, TF ;
Volpe, M ;
Cosentino, F .
CIRCULATION, 2004, 110 (18) :2889-2895
[10]   Therapeutic potential of matrix metalloproteinase inhibitors in atherosclerosis [J].
George, SJ .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (05) :993-1007